Cancer immunotherapy: novel strategies and clinical experiences

The 4th International Dresden Symposium on Immunotherapy of Cancer was held in Dresden, Germany from 21–22 June 2002. The 4th international Dresden symposium on Immunotherapy of Cancer reported on new insights into tumor-directed immune responses and on novel clinical trials including anti-tumor vac...

Full description

Saved in:
Bibliographic Details
Published in:Trends in immunology 2002-09, Vol.23 (9), p.428-429
Main Authors: Schmitz, Marc, Bornhäuser, Martin, Ockert, Detlef, Rieber, Ernst Peter
Format: Article
Language:English
Subjects:
allogeneic effector cells
Bone marrow
Cancer Vaccines - immunology
Clinical trials
Clinical Trials as Topic
dendritic cells
Dendritic Cells - immunology
Graft vs Host Disease - immunology
Graft vs Host Disease - prevention & control
Histocompatibility Antigens Class I - immunology
Histocompatibility Antigens Class II - immunology
Humans
Immune system
Immunotherapy
Immunotherapy - methods
Kidney cancer
Lymphocytes
Melanoma
Neoplasms - immunology
Neoplasms - therapy
Peptides
Peptides - immunology
Peptides - therapeutic use
Prostate cancer
Stem Cell Transplantation
Studies
T cell receptors
T cells
T-cell monitoring
Telomerase
Transplants & implants
tumor-associated antigens
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The 4th International Dresden Symposium on Immunotherapy of Cancer was held in Dresden, Germany from 21–22 June 2002. The 4th international Dresden symposium on Immunotherapy of Cancer reported on new insights into tumor-directed immune responses and on novel clinical trials including anti-tumor vaccination and treatment with alloreactive T cells and NK cells.
ISSN:1471-4906
1471-4981
DOI:10.1016/S1471-4906(02)02300-1